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Narcolepsy: A Key Role Minireview
for Hypocretins (Orexins)
a single-gene autosomal recessive trait with full pene-
trance.
The sleepiness of narcolepsy can be treated by a
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number of agents, such as amphetamine-like drugs andNorth Hills, California 91343
Modafinil, which increase arousal. Cataplexy is com-Department of Psychiatry and
monly treated with tricyclic antidepressants and by se-Brain Research Institute
lective serotonin reuptake inhibitors. Nishino and col-University of California at Los Angeles
leagues have shown that the selective serotonin reuptakeLos Angeles, California 90024
inhibitors and the antidepressants inhibit cataplexy in
proportion to their activation of norepinephrine recep-
tors. In contrast, prazosin, which blocks a1 noradrener-Two recent papers have linked narcolepsy to dysfunc-
gic receptors, greatly exacerbates cataplexy in bothtion of the newly discovered hypocretin (Hcrt) (orexin)
dogs and humans. Cholinergic agonists and the cholin-peptide system. The paper by Lin et al. (1999 [previous
esterase blocker physostigmine also exacerbate cata-issue of Cell]) examined the genetic correlate of canine
plexy, consistent with a role of cholinoceptive neuronsnarcolepsy, using the well-characterized Doberman
in triggering muscle tone suppression. Thus, the balancepinscher and Labrador retriever models. They found a
between the noradrenergic and cholinergic systems isdeletion in the transcripts of the hypocretin receptor 2
a major factor in the control of cataplexy.(Hcrtr2) gene in the narcoleptic Doberman and a differ-
In normal individuals, postural muscles maintain someent deletion in transcripts of the same receptor gene in
level of tone throughout waking and non-REM sleep.the narcoleptic Labrador. Lin et al. speculate that these
Only in REM sleep is muscle tone completely abolished.changes disrupt the proper membrane localization or
This suppression of tone prevents the motor programstransduction functions of this receptor. The paper by
generated in REM sleep from causing dangerous andChemelli et al. (1999 [this issue of Cell]) used a different
sleep-disrupting movements. The similarity between theapproach to arrive at a similar conclusion. They created
atonia in REM sleep and the atonia in cataplexy, anda knockout of the Hcrt gene in mice. Mice lacking Hcrt
the abnormally short latency to REM sleep onset shownhad abnormalities of sleep control resembling aspects
by narcoleptics, have led to the hypothesis that cata-of narcolepsy. Together these two studies implicate dys-
plexy may represent a triggering, in waking, of the mech-function of the Hcrt system or systems closely linked
anism that normally functions to suppress muscle toneto it in the pathophysiology of narcolepsy. The implica-
in REM sleep. Studies in the narcoleptic dog have sup-tions of these findings can best be understood by re-
ported this hypothesis and provided insights into theviewing the nature of narcolepsy and of the Hcrt system.
nature of the mechanisms controlling posture in waking.What Is Narcolepsy?
Recordings of brainstem neuronal activity in narcoleptic
Narcolepsy is a disease affecting approximately 1 in
dogs have shown that cataplexy is linked to the activa-
2,000 individuals (about 125,000 in the U.S.) and usually
tion of a population of cells in the medulla and pons
develops in the second or third decade of life with symp- that in normal animals is active only during REM sleep
toms progressing over a period of 1 or more years and (Siegel et al., 1991; Siegel, 1994). During REM sleep
then stabilizing. Narcolepsy is characterized by sleepi- and presumably during cataplexy, this pontomedullary
ness and cataplexy, which is a loss of muscle tone trig- system causes the release of glycine onto motoneurons,
gered by sudden strong emotions such as laughter and producing hyperpolarization (Figure 1).
anger. Attacks of cataplexy are usually over within sec- At cataplexy onset, at the same time as glycine begins
onds but in some narcoleptic patients can last for min- to be released, the norepinephrine-containing neurons
utes and be disabling. In contrast to sleep attacks, con- of the locus coeruleus, which are normally continuously
sciousness is maintained during cataplexy. In most active in waking, abruptly and completely cease dis-
narcoleptic patients, sleepiness rather than cataplexy charge (Wu et al., 1999). They also cease discharge in
is the more troublesome symptom. Narcoleptics go REM sleep. Norepinephrine released from these neu-
through life feeling the way most of us would feel if we rons is known to facilitate motoneurons (Figure 1). Thus,
had been awake for 24 hr. They awake refreshed from a combination of active inhibition and disfacilitation (re-
naps, but soon are sleepy again. Their nighttime sleep duced excitatory input) appears to underlie both cata-
is fragmented with less of the deeper stages of sleep. plexy and the muscle atonia of REM sleep.
Narcolepsy also has been reported in horses, cattle, What Are the Hypocretins (Orexins)?
and dogs. Some cases of canine narcolepsy are spo- In 1998, de Lecea et al., using directional tag PCR sub-
radic and these dogs cannot be bred to produce narco- traction, described a hypothalamus-specific mRNA that
leptic offspring. Occasionally, entire litters are born that encoded ªpreprohypocretin,º which was thought to be
develop the symptoms of narcolepsy at 1±4 months of the precursor of two peptides, Hcrt1 and -2. They named
age and show both sleepiness and cataplexy. In the these peptides hypocretins (Hcrts) to indicate their hy-
early 1970s, Dement, Mitler, and their colleagues found pothalamic localization and similarity to the gut hormone
that it was possible to breed these familial narcoleptic secretin. At about the same time, Sakurai et al. (1998)
Doberman pinschers or Labrador retrievers. The disor- were searching for ligands for certain cDNA sequences
that resembled G protein±coupled receptors but had noder is transmitted in the Dobermans and Labradors as
Cell
410
Figure 1. Possible Role of the Hypocretins
(Orexins) in the Pathology of Narcolepsy
The hypocretin (orexin)±containing neurons
are known to project to brainstem regions
linked to motor inhibition as well as to locus
coeruleus (norepinephrine), raphe (seroto-
nin), and laterodorsal tegmental nuclei (ace-
tylcholine) and ventral tegmental (dopamine)
neurons. They also project to forebrain re-
gions including posterior hypothalamus (his-
tamine), septal nucleus, and diagonal band
(acetylcholine) neurons and have major pro-
jections to the amygdala and basal forebrain
hypnogenic regions. Loss of function of the hypocretin system could cause cataplexy by disfacilitating the brainstem's motor excitatory
systems or by disinhibiting the brainstem's motor inhibitory system. Loss of function of the hypocretins could increase sleepiness by
disfacilitating the cholinergic and aminergic arousal systems or by disinhibiting the forebrain's hypnogenic systems. The few physiological
studies done to date suggest that the hypocretins are usually excitatory; therefore, these two possibilities are highlighted in the figure.
known ligands, i.e., orphan receptors. They identified Hcrt levels. Genetically obese mice have downregulated
Hcrt gene expression. Microinjection of Hcrt and in somepeptides that bind to and activate two related receptors.
cases intracerebroventricular administration triggersBecause they found that these peptide ligands stimu-
feeding (Sweet et al., 1999) and increases metaboliclated food intake, they named them ªorexinsº after the
rate.Greek word for appetite. The peptides described by de
The Link between Narcolepsy and the HypocretinsLecea et al. and Sakurai et al. are identical.
The two apparently unrelated topics of a putative lateralAnatomical studies determined that the somas of the
hypothalamic feeding hormone and a disease character-Hcrt-producing cells were restricted to the hypothala-
ized by episodes of sleepiness and sudden losses ofmus and concentrated in the perifornical nucleus and
muscle tone have now been forever united by the workin the dorsal, lateral, and posterior hypothalamus. The
of Lin et al. (1999) and Chemelli et al. (1999). The narco-mRNA for the Hcrts is expressed by embryonic day 18
leptic dogs studied by Lin et al. have clear episodes ofin rats and increases dramatically after postnatal day
cataplexy, disturbed sleep, and evidence of sleepiness21 (de Lecea et al., 1998). Although the cell bodies of
resembling that shown by human narcoleptics. They areHcrt-producing neurons are entirely restricted to the
also similar to human narcoleptics in their response tohypothalamus, they have widespread axonal projec-
drugs that exacerbate and ameliorate cataplexy andtions. In addition to dense hypothalamic projections, the
sleepiness.limbic system, thalamus, subthalamic nucleus, substan-
It remains to be determined if the Hcrt gene knockouttia nigra, raphe, locus coeruleus, ventral tegmental area,
mice created by Chemelli et al. have the features ofmedullary reticular formation, nucleus of the solitary
human and canine narcolepsy. These mice lack the Hcrttract, and other brainstem regions are innervated by
peptides, in contrast to the dogs, which have mutationsthese cells (Peyron et al., 1998). The neocortex also
in the Hcrt2 receptor. Although they have periods ofreceives projections. Hcrt receptors are distributed
ªbehavioral arrest,º it is not yet clear if these includethroughout the innervated regions with a striking segre-
periods of cataplexy or if they are all direct transitionsgation of the two receptor types within rat brain (Trivedi
from waking into REM sleep. The triggers for these epi-et al., 1998). Hcrtr2 mRNA is mainly expressed in cere-
sodes differ from those in the dogs, with emotional ex-
bral cortex, nucleus accumbens, subthalamic and para-
citement associated with food intake not being a com-
ventricular thalamic nuclei, and anterior pretectal nu-
mon instigator of attacks in the mice. It may well be that
cleus. Lin et al. (1999) implicate the Hcrtr2 in canine an identical knockout in a dog would produce symptoms
narcolepsy. similar to those seen in the narcoleptic Doberman and
Physiological studies showed that Hcrt release raises Labrador, but that the brain of the mouse does not con-
cytoplasmic calcium levels by opening plasma mem- tain the machinery required for full expression of the
brane channels and increases the release of both syndrome seen in humans and dogs. Conversely, an
gamma amino butyric acid (GABA) and glutamate from Hcrtr2 knockout mouse might mimic more closely the
axon terminals (van den Pol et al., 1998). Hcrt neurons symptoms seen in dogs and humans. Sleep is disrupted
have close and reciprocal connections with hypothala- in the Hcrt knockout mice although it is not clear that
mic neurons containing neuropeptide Y (NPY) (Horvath they are ªsleepy.º Finally the pharmacologic response
et al., 1999), which strongly stimulates appetite, sug- of these symptoms is not reported in the Chemelli et al.
gesting that Hcrt neurons have a role in feeding and paper. Clearly much work remains to be done to fully
metabolic control. The entire lateral hypothalamic region characterize this new model of narcolepsy. Neverthe-
in which the Hcrt neurons are embedded has long been less, the presence of sleep onset REM sleep periods
thought of as an appetite control ªcenter.º and disrupted sleep in both dog and knockout mouse
Pharmacological and physiological studies indicate provides strong support for the proposed involvement
that Hcrt neurons have a role in appetite (Sakurai et of Hcrt in narcolepsy.
al., 1998). Hcrt-producing cells express leptin receptor How Does the Finding of Hcrt Linkage Explain
immunoreactivity (Horvath et al., 1999). Insulin-induced the Symptoms of Narcolepsy?
hypoglycemia greatly increases the level of the Hcrt A remarkable link appears to exist between the anatomy
of the Hcrt system and the triggering of cataplexy.precursor protein, whereas leptin treatment decreases
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Peyron et al. (1998) report that the densest extrahypo- 1997), suggesting a possible role for Hcrts in other neu-
thalamic projection of the Hcrt system is directed at the rodegenerative diseases. An intriguing clue to the possi-
locus coeruleus. As outlined above, cessation of activity ble role of Hcrts in degeneration comes from the recent
in locus coeruleus cells precedes and accompanies cat- report of Ichinose et al. (1998). They found that Hcrt2
aplexy, and narcoleptic dogs have a relatively low rate induced an outward current in peritoneal macrophages,
of locus coeruleus discharge (Wu et al., 1999). In normal indicating that the Hcrts can modulate macrophage
animals, locus coeruleus cells never cease discharge functions through the activation of Ca21-dependent K1
during waking. Hcrt administration has been shown to channels. It remains to be determined if the Hcrts have
greatly increase c-Fos labeling in locus coeruleus neu- similar action on brain microglia. However, such a role
rons (Date et al., 1999), an indication that Hcrts increase could unite the loss of Hcrt function with the postulated
discharge in these cells. Thus, it can be argued that a but unproven immune link to narcolepsy.
malfunctioning Hcrt system, by removing a source of Malfunction of the Hcrt system might be expected
excitation from the locus coeruleus, would increase the to affect several systems not implicated in sleep and
propensity for cataplexy. However, the Hcrt2 receptor arousal control. van den Pol has shown that Hcrt neu-
that is mutated in narcoleptic dogs is not present at rons strongly innervate the spinal cord. The innervation
high levels in the locus coeruleus of rats. If this is also is targeted to dorsal regions involved in autonomic and
true in the dog, one may hypothesize that the Hcrt2 pain control and may explain the profound analgesia
receptor mutation leads to a more widespread loss of produced by lateral hypothalamic stimulation. Hypo-
Hcrt function than would be caused by Hcrt2 receptor function of this system might be involved in pain syn-
malfunction alone. This may occur through disturbed dromes, but there has so far been no report of any
feedback regulation or degeneration of Hcrt neurons linkage of narcolepsy to altered pain perception.
resulting in a direct or indirect disfacilitation of locus A simplistic prediction based on the role of Hcrts in
coeruleus cells. appetite stimulation would be that narcoleptics should
Although we now understand key elements of the have a gross abnormality of food intake resulting in
system responsible for cataplexy, the neurons responsi- anorexia. However, there is no evidence for anorexia in
ble for the sleepiness of narcolepsy have not been iden- unmedicated narcoleptics. Conversely, although there
tified. Several populations of cells known to increase may be some modulation of narcoleptic symptomatol-
arousal or increase sleepiness exist. Reduced excitation ogy as a function of food intake, there is no strong
of the noradrenergic cells of the locus coeruleus, sero- evidence for the major change in symptoms that would
tonergic cells of the raphe, dopaminergic cells of the be predicted by the effects of hypoglycemia on Hcrt
hypothalamus and mesopontine region, or histaminer- neurons. Similarly, hypofunction of the nucleus accum-
gic cells of the posterior hypothalamus could reduce bens, a site for reward integration, might suggest a syn-
arousal levels. Reduced excitation of cholinergic neu- drome of ahedonia in narcoleptics, but none has been
rons of the basal forebrain and brainstem would also reported. However, there is evidence for higher rates of
impair behavioral and EEG arousal. depression in narcolepsy. This might be explained by
Conversely, the Hcrts could directly or indirectly in- reduced Hcrt excitation in the nucleus accumbens.
hibit sleep active neurons in the basal forebrain, amyg- In general the deficits seen in animals with gene
dala, or the hypnogenic regions of the nucleus solitarius. knockouts must be thought of as due to a combination
If this were the case, dysfunction of these projections of loss of gene function combined with the body's com-
would increase sleepiness. If the Hcrts have a role in pensatory response to the loss. Receptor upregulation,
monoamine and acetylcholine release similar to the role synaptic sprouting, biochemical changes within the af-
they have been shown to have in GABA and glutamate fected cells, loss of trophic factors, immune interactions,
release, Hcrt hypofunction could cause the accumula- and other changes may combine to produce the re-
tion of dopamine and the upregulation of several recep-
sulting phenotype. NPY neurons are adjacent to and
tor types that is observed in the narcoleptic dogs. It
have close synaptic interactions with Hcrt cells. NPY
is significant that the hypocretin neurons have direct
administration produces a more potent activation ofprojections to all of the arousal and sleepiness modulat-
food intake than does Hcrt administration. However, theing cell groups mentioned above.
NPY knockout mouse has normal weight regulation andRecent work has shown that there is neuronal degen-
response to food deprivation. On the other hand, theseeration in limbic forebrain regions in the narcoleptic
mice are prone to seizures and have elevated responsesdogs. This degeneration peaks before symptom onset
to leptin (Erickson et al., 1996). It may well be a similar(Siegel et al., 1999). Degeneration is maximal in the
reorganization of brain systems interacting with Hcrtamygdala and septal nuclei and is also elevated in the
neurons that causes the symptoms of narcolepsy, ratherdiagonal band, thalamus, and hypothalamic regions.
than the immediate effects of the Hcrt receptor malfunc-These areas receive a moderate to heavy Hcrt innerva-
tion or Hcrt disruption.tion. Tafti et al. (1996) have reported increased expres-
Relevance to Human Diseasesion of major histocompatibility class II molecules in
Mutations of the Hcrt system may be responsible forbrain microglia of narcoleptic dogs, with a time course
some proportion of human narcolepsy cases. However,similar to that of the degeneration, consistent with direct
it is unlikely that most human narcoleptics have a muta-or indirect immune activation. Could the Hcrt2 gene
tion in their Hcrt or Hcrtr genes. Most narcoleptics havemutation be linked to the degenerative changes? The
no narcoleptic relatives, ruling out the autosomal reces-human Hcrt precursor gene is located at chromosome
sive mode of inheritance seen in the dogs. The typical17q21±22, a gene locus that has been implicated in
a series of neurodegenerative disorders (Basun et al., onset of symptoms in the second decade of life or later
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immune regulation, because most HLA-linked diseases Horvath, T.L., Diano, S., and van den Pol, A.N. (1999). J. Neurosci.
are autoimmune in nature, and because of the evidence 19, 1072±1087.
that environmental triggers might be involved, it has Ichinose, M., Asai, M., Sawada, M., Sasaki, K., and Oomura, Y.
been speculated that narcolepsy might be an autoim- (1998). FEBS Lett. 440, 51±54.
mune disorder. An obvious question is whether there is Ida, T., Nakahara, K., Katayama, T., Murakami, N., and Nakazato,
M. (1999). Brain Res. 821, 526±529.evidence for an immune attack on the Hcrt2 receptor
in human narcolepsy. Since receptors are continuously Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X.,
de Jong, P.J., Nishino, S., and Mignot, E. (1999). Cell 98, 365±376.regenerated, any immune attack that affected only the
Mignot, E. (1998). Neurology 50(2), S16±S22.receptors would have to continue for the duration of the
disease. No such autoimmune process has so far been Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C.,
Sutcliffe, J.G., and Kilduff, T.S. (1998). J. Neurosci. 18, 9996±10015.detected. Alternatively, irreversible damage to axon ter-
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M.,minals or to the hypocretin neurons themselves, creating
Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson,the equivalent of an Hcrt knockout, might cause the
S., et al. (1998). Cell 92, 573±585.disorder. The deficit in human narcolepsy may also be
Siegel, J.M. (1994). In Principles and Practice of Sleep Medicine,downstream of the Hcrt system. For example, immune-
M.H. Kryger, T. Roth, and W.C. Dement, eds. (Philadelphia: W.B.mediated damage to neurons or receptors in the locus
Saunders Company), pp. 125±144.
coeruleus, amygdala, or basal forebrain sleep related
Siegel, J.M., Nienhuis, R., Fahringer, H., Paul, R., Shiromani, P.,regions might produce the syndrome even with normal
Dement, W.C., Mignot, E., and Chiu, C. (1991). Science 262, 1315±
function of the Hcrt neurons and the Hcrt2 receptor. 1318.
Therapeutic Implications Siegel, J.M., Nienhuis, R., Gulyani, S., Ouyang, S., Wu, M.F., Mignot,
Current treatments for narcolepsy provide some symp- E., Switzer, R.C., and Cornford, M. (1999). J. Neurosci 19, 248±257.
tomatic relief at the expense of substantial side effects. Sweet, D.C., Levine, A.S., Billington, C.J., and Kotz, C.M. (1999).
The nature of the altered function caused by the Hcrt2 Brain Res. 821, 535±538.
receptor mutation in the dogs is at present unclear. If Tafti, M., Nishino, S., Aldrich, M.S., Liao, W., Dement, W.C., and
the mutations cause a moderately diminished functional Mignot, E. (1996). J. Neurosci. 16, 4588±4595.
response to their ligand, administration of Hcrts might Trivedi, P., Yu, H., MacNeil, D.J., Van der Ploeg, L.H., and Guan,
improve symptoms. Similarly, in the knockout mouse, X.M. (1998). FEBS Lett. 438, 71±75.
the effects of the loss of Hcrt might be reversed by Hcrt van den Pol, A.N., Gao, X.B., Obrietan, K., Kilduff, T.S., and Belousov,
administration. If similar pathologies exist in humans, A.B. (1998). J. Neurosci. 18, 7962±7971.
the same treatments could be effective. However, since Wu, M.F., Gulyani, S., Yao, E., Mignot, E., Phan, B., and Siegel, J.M.
(1999). Neuroscience 91, 1389±1399.Hcrt has been reported to increase eating, metabolic
rate, and gastric acid secretion, and Hcrts may have a
role in the control of anterior pituitary hormones and
pain regulation, a large number of brain systems would
likely be affected by Hcrt administration. The possibility
of effects on the immune system should also be consid-
ered. Moreover, Hcrts produce ªwet dog shakesº in rats,
an indication of stress or anxiety, and high doses pro-
duce seizures in rats (Ida et al., 1999). Since the Hcrt
system is strongly connected with the noradrenergic
and serotonergic systems, themselves diffusely pro-
jecting, both therapeutic and deleterious effects could
be mediated by secondary alteration in the activity of
these aminergic systems. The development of specific
Hcrt agonists for Hcrtr2, the receptor mutated in narco-
leptic dogs, might reduce these problems. Since some
of the most successful neuroactive therapeutic agents
manipulate the widely projecting aminergic systems,
there is reason to hope that manipulation of the Hcrt
system will also lead to useful drug therapies for narco-
lepsy.
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